<p>PetMed Express, Inc.（纳斯达克代码：PETS - 获取免费报告）在 12 月份的空头头寸出现了显著下降。截至 12 月 31 日，空头头寸总计为 1,056,449 股，较 12 月 15 日的 2,698,921 股下降了 60.9%。目前，该股票的 5.0% 股份被做空。根据平均每日交易量 1,489,468 股，空头头寸比率目前为 0.7 天。</p>
<p>获取 <strong>PetMed Express</strong> 警报：</p>
<h2>机构资金流入和流出</h2>
<ul>
<li>Petco Health &amp; Wellness 在每股收益超预期后是否摆脱困境？</li>
</ul>
<p>几家机构投资者和对冲基金最近对该股票的持仓进行了调整。R Squared Ltd 在第二季度购买了价值约 34,000 美元的 PetMed Express 新股份。Occudo Quantitative Strategies LP 在第二季度获得了价值约 51,000 美元的 PetMed Express 新持仓。Oxford Asset Management LLP 在第二季度获得了价值约 55,000 美元的 PetMed Express 新持仓。CIBC Private Wealth Group LLC 在第三季度购买了价值约 75,000 美元的 PetMed Express 新持仓。最后，Bridgeway Capital Management LLC 在第二季度将其在 PetMed Express 的股份增加了 96.2%。Bridgeway Capital Management LLC 目前拥有 40,800 股该公司股票，价值 135,000 美元，此前在上个季度又购买了 20,000 股。目前，73.33% 的股票由机构投资者持有。</p>
<h2>PetMed Express 股票上涨 1.7%</h2>
<p>周三，PETS 股票上涨 0.06 美元，达到 3.49 美元。该股票交易了 174,936 股，较其平均交易量 337,258 股有所减少。该公司的市值为 7458 万美元，市盈率为-1.32，贝塔值为 0.65。该公司有 50 日移动平均线为 2.66 美元，200 日移动平均线为 2.85 美元。PetMed Express 的 1 年最低价为 1.57 美元，1 年最高价为 5.58 美元。</p>
<ul>
<li>这是唯一一只不在困境中的宠物股票</li>
</ul>
<p>PetMed Express（纳斯达克代码：PETS - 获取免费报告）最后一次发布财报是在 12 月 19 日，周五。该公司报告每股收益（EPS）为（0.41）美元，低于分析师一致预期的 0.04 美元，差距为（0.45）美元。PetMed Express 的股本回报率为-40.26%，净利润率为-28.22%。该业务在本季度的收入为 4436 万美元。根据分析师的预测，PetMed Express 在当前财年将发布 0.19 美元的每股收益。</p>
<h2>华尔街分析师预测增长</h2>
<p>多位分析师对 PETS 股票发布了报告。Wall Street Zen 在 10 月 18 日的研究报告中将 PetMed Express 的评级从 “持有” 下调至 “卖出”。Zacks Research 在 9 月 29 日的研究报告中将 PetMed Express 的评级从 “强烈卖出” 上调至 “持有”。最后，Weiss Ratings 在 12 月 29 日的研究报告中重申了对 PetMed Express 的 “卖出（e+）” 评级。一位分析师对该股票给予了 “持有” 评级，两位分析师给予了 “卖出” 评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “卖出”，平均目标价为 3.20 美元。</p>
<ul>
<li>这 5 只宠物护理股票中的一只可能成为下一个空头挤压</li>
</ul>
<p><strong>阅读我们关于 PETS 的最新报告</strong></p>
<h2>PetMed Express 公司简介</h2>
<p>（获取免费报告）</p>
<p>PetMed Express, Inc.以 1-800-PetMeds 品牌名义运营，作为一家在线和目录基础的宠物药房和零售供应商。该公司直接向消费者分发处方和非处方药物、营养补充剂、跳蚤和蜱虫控制产品以及一系列宠物健康用品。通过其位于佛罗里达州德尔雷海滩的持牌兽医药房，PetMed Express 为狗、猫和其他伴侣动物处理订单，提供品牌和仿制产品以及自有品牌配方。</p>
<p>PetMed Express 于 1996 年由 Marc Puleo 创立，基于为寻求可靠兽医药物的宠物主人提供便利和节省成本的理念建立了其业务。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票比 PetMed Express 更好</li>
<li>这个 AI 机会旨在随着需求的变化而发展</li>
<li>将这些代码输入您的普通经纪账户</li>
<li>家族信托如何帮助保护您的财富</li>
<li>为什么特朗普和马斯克突然关心福特诺克斯</li>
<li>一项价值数万亿的美国 “出生权” 索赔 - 静悄悄地激活</li>
</ul>
<p><em>此即时新闻警报由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 PetMed Express 吗？</h2>
<p>在考虑 PetMed Express 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 PetMed Express 并不在名单上。</p>
<p>虽然 PetMed Express 目前在分析师中被评为 “卖出”，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

PETS

<p>PetMed Express, Inc.（纳斯达克代码：PETS）在短期空头头寸方面经历了显著下降，12 月份下降了 60.9%，降至 1,056,449 股。目前，其 5.0% 的股份被做空，基于平均每日成交量 1,489,468 股，覆盖天数比率为 0.7 天。股价上涨了 1.7%，达到 3.49 美元，市值为 7458 万美元。分析师的评级意见不一，平均目标价为 3.20 美元，显示出总体看跌的前景</p>

<p>PetMed Express, Inc. (NASDAQ:PETS - Get Free Report) was the target of a significant drop in short interest in December. As of December 31st, there was short interest totaling 1,056,449 shares, a drop of 60.9% from the December 15th total of 2,698,921 shares. Currently, 5.0% of the shares of the stock are sold short. Based on an average daily volume of 1,489,468 shares, the short-interest ratio is presently 0.7 days. Based on an average daily volume of 1,489,468 shares, the short-interest ratio is presently 0.7 days. Currently, 5.0% of the shares of the stock are sold short.</p>
<div class="lb-trans"><p>PetMed Express, Inc.（纳斯达克代码：PETS - 获取免费报告）在 12 月份的空头头寸出现了显著下降。截至 12 月 31 日，空头头寸总计为 1,056,449 股，较 12 月 15 日的 2,698,921 股下降了 60.9%。目前，该股票的 5.0% 股份被做空。根据平均每日交易量 1,489,468 股，空头头寸比率目前为 0.7 天。</p>
</div><p>Get <strong>PetMed Express</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>PetMed Express</strong> 警报：</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><ul>
<li>Is Petco Health &amp; Wellness Out of the Doghouse on an EPS beat?</li>
</ul>
<div class="lb-trans"><ul>
<li>Petco Health &amp; Wellness 在每股收益超预期后是否摆脱困境？</li>
</ul>
</div><p>Several institutional investors and hedge funds have recently made changes to their positions in the stock. R Squared Ltd purchased a new stake in PetMed Express during the second quarter valued at about $34,000. Occudo Quantitative Strategies LP acquired a new position in shares of PetMed Express during the second quarter worth approximately $51,000. Oxford Asset Management LLP acquired a new position in PetMed Express in the 2nd quarter valued at approximately $55,000. CIBC Private Wealth Group LLC bought a new position in shares of PetMed Express during the 3rd quarter worth about $75,000. Finally, Bridgeway Capital Management LLC boosted its stake in PetMed Express by 96.2% in the 2nd quarter. Bridgeway Capital Management LLC now owns 40,800 shares of the company's stock valued at $135,000 after buying an additional 20,000 shares in the last quarter. 73.33% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>几家机构投资者和对冲基金最近对该股票的持仓进行了调整。R Squared Ltd 在第二季度购买了价值约 34,000 美元的 PetMed Express 新股份。Occudo Quantitative Strategies LP 在第二季度获得了价值约 51,000 美元的 PetMed Express 新持仓。Oxford Asset Management LLP 在第二季度获得了价值约 55,000 美元的 PetMed Express 新持仓。CIBC Private Wealth Group LLC 在第三季度购买了价值约 75,000 美元的 PetMed Express 新持仓。最后，Bridgeway Capital Management LLC 在第二季度将其在 PetMed Express 的股份增加了 96.2%。Bridgeway Capital Management LLC 目前拥有 40,800 股该公司股票，价值 135,000 美元，此前在上个季度又购买了 20,000 股。目前，73.33% 的股票由机构投资者持有。</p>
</div><h2>PetMed Express Stock Up 1.7%</h2>
<div class="lb-trans"><h2>PetMed Express 股票上涨 1.7%</h2>
</div><p>Shares of PETS stock traded up $0.06 on Wednesday, reaching $3.49. 174,936 shares of the stock were exchanged, compared to its average volume of 337,258. The stock has a market cap of $74.58 million, a P/E ratio of -1.32 and a beta of 0.65. The firm has a 50 day moving average of $2.66 and a two-hundred day moving average of $2.85. PetMed Express has a 1-year low of $1.57 and a 1-year high of $5.58.</p>
<div class="lb-trans"><p>周三，PETS 股票上涨 0.06 美元，达到 3.49 美元。该股票交易了 174,936 股，较其平均交易量 337,258 股有所减少。该公司的市值为 7458 万美元，市盈率为-1.32，贝塔值为 0.65。该公司有 50 日移动平均线为 2.66 美元，200 日移动平均线为 2.85 美元。PetMed Express 的 1 年最低价为 1.57 美元，1 年最高价为 5.58 美元。</p>
</div><ul>
<li>Here’s The One Pet Stock That’s Not in the Doghouse</li>
</ul>
<div class="lb-trans"><ul>
<li>这是唯一一只不在困境中的宠物股票</li>
</ul>
</div><p>PetMed Express (NASDAQ:PETS - Get Free Report) last posted its earnings results on Friday, December 19th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by ($0.45). PetMed Express had a negative return on equity of 40.26% and a negative net margin of 28.22%.The business had revenue of $44.36 million for the quarter. On average, equities research analysts predict that PetMed Express will post 0.19 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>PetMed Express（纳斯达克代码：PETS - 获取免费报告）最后一次发布财报是在 12 月 19 日，周五。该公司报告每股收益（EPS）为（0.41）美元，低于分析师一致预期的 0.04 美元，差距为（0.45）美元。PetMed Express 的股本回报率为-40.26%，净利润率为-28.22%。该业务在本季度的收入为 4436 万美元。根据分析师的预测，PetMed Express 在当前财年将发布 0.19 美元的每股收益。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>A number of analysts have issued reports on PETS shares. Wall Street Zen downgraded PetMed Express from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a research note on Saturday, October 18th. Zacks Research raised shares of PetMed Express from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Monday, September 29th. Finally, Weiss Ratings restated a &#34;sell (e+)&#34; rating on shares of PetMed Express in a research note on Monday, December 29th. One analyst has rated the stock with a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of &#34;Sell&#34; and an average target price of $3.20.</p>
<div class="lb-trans"><p>多位分析师对 PETS 股票发布了报告。Wall Street Zen 在 10 月 18 日的研究报告中将 PetMed Express 的评级从 “持有” 下调至 “卖出”。Zacks Research 在 9 月 29 日的研究报告中将 PetMed Express 的评级从 “强烈卖出” 上调至 “持有”。最后，Weiss Ratings 在 12 月 29 日的研究报告中重申了对 PetMed Express 的 “卖出（e+）” 评级。一位分析师对该股票给予了 “持有” 评级，两位分析师给予了 “卖出” 评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “卖出”，平均目标价为 3.20 美元。</p>
</div><ul>
<li>One of these 5 Pet Care Stocks Can Be the Next Short Squeeze</li>
</ul>
<div class="lb-trans"><ul>
<li>这 5 只宠物护理股票中的一只可能成为下一个空头挤压</li>
</ul>
</div><p><strong>Read Our Latest Report on PETS</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 PETS 的最新报告</strong></p>
</div><h2>PetMed Express Company Profile</h2>
<div class="lb-trans"><h2>PetMed Express 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.</p>
<div class="lb-trans"><p>PetMed Express, Inc.以 1-800-PetMeds 品牌名义运营，作为一家在线和目录基础的宠物药房和零售供应商。该公司直接向消费者分发处方和非处方药物、营养补充剂、跳蚤和蜱虫控制产品以及一系列宠物健康用品。通过其位于佛罗里达州德尔雷海滩的持牌兽医药房，PetMed Express 为狗、猫和其他伴侣动物处理订单，提供品牌和仿制产品以及自有品牌配方。</p>
</div><p>Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.</p>
<div class="lb-trans"><p>PetMed Express 于 1996 年由 Marc Puleo 创立，基于为寻求可靠兽医药物的宠物主人提供便利和节省成本的理念建立了其业务。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than PetMed Express</li>
<li>This AI Opportunity Was Built to Evolve With Demand</li>
<li>Punch these codes into your ordinary brokerage account</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>Why Trump and Musk suddenly care about Fort Knox</li>
<li>A U.S. “birthright” claim worth trillions - activated quietly</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比 PetMed Express 更好</li>
<li>这个 AI 机会旨在随着需求的变化而发展</li>
<li>将这些代码输入您的普通经纪账户</li>
<li>家族信托如何帮助保护您的财富</li>
<li>为什么特朗普和马斯克突然关心福特诺克斯</li>
<li>一项价值数万亿的美国 “出生权” 索赔 - 静悄悄地激活</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻警报由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in PetMed Express Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 PetMed Express 吗？</h2>
</div><p>Before you consider PetMed Express, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 PetMed Express 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PetMed Express wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 PetMed Express 并不在名单上。</p>
</div><p>While PetMed Express currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 PetMed Express 目前在分析师中被评为 “卖出”，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

PetMed Express, Inc.（NASDAQ 代码：PETS）的空头头寸减少了 60.9%